Zacks Research Forecasts Danaher’s Q2 Earnings (NYSE:DHR)

Danaher Co. (NYSE:DHR) – Research analysts at Zacks Research lowered their Q2 2025 EPS estimates for Danaher in a report released on Thursday, November 21st. Zacks Research analyst R. Department now expects that the conglomerate will earn $1.90 per share for the quarter, down from their prior forecast of $1.91. The consensus estimate for Danaher’s current full-year earnings is $7.50 per share. Zacks Research also issued estimates for Danaher’s Q4 2025 earnings at $2.33 EPS and FY2025 earnings at $8.22 EPS.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business’s revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the company earned $2.02 EPS.

Other analysts have also issued research reports about the company. Evercore ISI increased their price target on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Barclays reduced their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 23rd. UBS Group dropped their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Stephens reissued an “overweight” rating and issued a $315.00 price objective on shares of Danaher in a research report on Wednesday, October 23rd. Finally, Raymond James dropped their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $287.16.

Danaher Price Performance

NYSE:DHR opened at $236.53 on Monday. The firm has a market capitalization of $170.84 billion, a price-to-earnings ratio of 45.14, a PEG ratio of 4.34 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The business has a 50 day simple moving average of $256.66 and a 200-day simple moving average of $259.81. Danaher has a 1 year low of $215.68 and a 1 year high of $281.70.

Institutional Investors Weigh In On Danaher

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Benjamin Edwards Inc. increased its position in Danaher by 1.8% in the 2nd quarter. Benjamin Edwards Inc. now owns 2,153 shares of the conglomerate’s stock valued at $538,000 after acquiring an additional 38 shares during the period. Wedge Capital Management L L P NC increased its holdings in shares of Danaher by 3.2% in the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 38 shares during the period. Patrick M Sweeney & Associates Inc. grew its position in Danaher by 3.4% in the 2nd quarter. Patrick M Sweeney & Associates Inc. now owns 1,230 shares of the conglomerate’s stock valued at $307,000 after buying an additional 40 shares during the last quarter. Trust Co of Kansas increased its stake in Danaher by 4.1% in the 2nd quarter. Trust Co of Kansas now owns 1,022 shares of the conglomerate’s stock valued at $255,000 after buying an additional 40 shares during the period. Finally, Abacus Planning Group Inc. lifted its stake in shares of Danaher by 0.7% in the 2nd quarter. Abacus Planning Group Inc. now owns 5,439 shares of the conglomerate’s stock worth $1,359,000 after acquiring an additional 40 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were given a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s payout ratio is currently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.